Global Market Study on Glycobiology: Rising Application of Glycobiology Enzymes for Novel Drug Development to Boost Demand
Glycobiology Market is segmented by Instruments, Enzymes, Consumables, Reagent Kits, Galactosidases, GlcNAc Transferases, Drug Discovery, and Development, Diagnostic Applications
Glycobiology is the pursuit to decipher information communicated by carbohydrate molecules – the carbohydrate code or glycocode. Glycans or carbohydrates are one of the fundamental classes of macromolecules present in biological systems, and are formed by individual sugar units called monosaccharides, linked to each other in multiple ways.
Glycans are involved in every aspect of the biochemistry of life, in a way that proteins and peptides cannot be evaluated without understanding the science that deals with the study of synthesis, structural elucidation, functional property identification, and mechanism of interaction of glycans with biological molecules such as lipids and proteins. The global glycobiology market size is projected to expand more than threefold over the next ten years (2020 to 2030).
Find Out More about the Report Coverage
- Merck KGaA
- Bio-Techne Corporation
- Bruker Corporation
- Thermo Fisher Scientific, Inc.
- Shimadzu Corporation
- ProZyme Inc.
- NEB Inc.
- Agilent Technologies
- New England Biolabs
- Takara Bio
- Waters Corporation
- Danaher Corporation
Glycobiology Market Trends
Chronic diseases such as cancer and diabetes have become a major reason for increasing research in the field of drug development, which is leading to increasing R&D expenditure by pharmaceutical companies, thus boosting revenue growth of the global glycobiology market. Increasing funding through government bodies is expected to boost revenue growth of the market over the forecast period.
Factors such as continuous technological advancements, and availability of products to conduct protocol with high specificity and sensitivity, are expected to boost revenue growth of the global glycobiology market over the years ahead. However, factors such as high product cost and low availability of skilled professionals is expected to hamper revenue growth of the global glycobiology market in the future.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Regional Analysis of Glycobiology Market
At nearly 45%, North America is projected to retain its dominance over the global glycobiology market share through 2030. The market in the U.S. is expected to remain dominant for glycobiology in the North America glycobiology market.
Europe is set to remain the second-largest market for glycobiology over the forecast period. The APAC region is expected to witness high growth, majorly due to increasing number of research initiatives being conducted in countries such as Japan and China.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
COVID-19 Impact on Glycobiology Market
The most unprecedented operational and economic challenges have emerged as a result of the COVID-19 pandemic across the world. Significant time will be required to develop and commercialize effective treatment options for new coronavirus pathogens.
These collective challenges are estimated to slow down industrial and academic research of cancer and diabetes conditions in the coming quarters of 2020 and 2021. In addition, local governments are prioritizing healthcare resources to tackle COVID-19 pandemic challenges, which is also expected to slow down the glycobiology market growth in the short-term.
The global glycobiology market is expected to experience short-term slowdown, followed by market recovery to pre-pandemic demand in the second half of 2021, owing to the availability of a COVID-19 vaccine and treatment by then. This will reflect in terms of the recovery of developed and emerging economies from COVID-19.
Explore Persistence Market Research’s expertise in promulgation of the business !
The global glycobiology market is projected to expand at a rapid pace over the next ten years, and grow 3.5X its current size by the year 2030. Market players can look to the North American region, especially the U.S., for increasing their market share and profits, as this region will continue to dominate the global glycobiology landscape right though the year 2030.
Key Segments of Glycobiology Market
Questions Answered in PMR’s Glycobiology Market Report
- Which regions will continue to remain the most profitable regional markets for glycobiology market players?
- Which factors will induce a change in the demand for glycobiology during the assessment period?
- What are the different opportunities available for emerging players in the glycobiology market?
- How are supply-side and demand-side drivers impacting the glycobiology market?
- How will changing trends impact the glycobiology market?
- How can market players capture the low-hanging opportunities in the glycobiology market in developed regions?
- Which companies are leading the glycobiology market?
- What are the winning strategies of stakeholders in the glycobiology market to upscale their position in this landscape?